e-learning
resources
ERJ
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease
Marras Theodore K., Campitelli Michael A., Kwong Jeffrey C., Lu Hong, Brode Sarah K., Marchand-Austin Alex, Gershon Andrea S., Jamieson Frances B.
Source:
Eur Respir J 2016; 48: 928-931
Journal Issue:
September
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Marras Theodore K., Campitelli Michael A., Kwong Jeffrey C., Lu Hong, Brode Sarah K., Marchand-Austin Alex, Gershon Andrea S., Jamieson Frances B.. Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease. Eur Respir J 2016; 48: 928-931
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Salivary SLPI and disease severity in bronchiectasis
Risk score of drug-induced liver injury among new tuberculosis patients
PG19 Heart-lung interaction
Related content which might interest you:
Nontuberculous mycobacterial infection in chronic obstructive pulmonary disease
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
Impact of pulmonary tuberculosis infection on chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011
Non-tuberculous mycobacterial lung disease and COPD
Source: Eur Respir Monogr 2015; 69: 172-184
Year: 2015
Change in pulmonary function among patients with bronchiectasis with or without non-tuberculous mycobacterial pulmonary disease
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019
Chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension are the conditions predisposing to non-tuberculous mycobacterial lung disease (NTMLD)
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011
History of pulmonary tuberculosis was associated with lung microbiome change in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: 782-800
Year: 2007
Management of pulmonary nontuberculous mycobacteria disease
Source: Eur Respir Monogr 2018; 81: 222-237
Year: 2018
Non-tuberculous mycobacterial pulmonary disease
Source: Eur Respir J, 54 (1) 1900250; 10.1183/13993003.00250-2019
Year: 2019
Comorbidity: pulmonary tuberculosis and chronic obstructive pulmonary disease.
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Clinical characteristics of postoperative pulmonary infection in lung cancer patients with obstructive pulmonary disease: the trend of microorganisms in bronchial colonization
Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology
Year: 2006
Obstructive lung disease in patients with treated pulmonary tuberculosis
Source: Annual Congress 2011 - Pulmonary and extrapulmonary tuberculosis
Year: 2011
Non tuberculous mycobacterial pulmonary disease in the elderly
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
When is an infectious disease? The clinical spectrum of nontuberculous mycobacterial pulmonary disease
Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Year: 2019
Chronic obstructive pulmonary disease and nosocomial infections
Source: Eur Respir J 2005; 26: Suppl. 49, 285s
Year: 2005
Pulmonary nontuberculous mycobacerial disease in elderly patients
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020
Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019
Hypoperfusion is the main risk factor for the development of non-tuberculous mycobacterial lung disease in CTEPH
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013
Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 60s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept